Skip to Content

Patiromer use while Breastfeeding

Drugs containing Patiromer: Veltassa

Medically reviewed by Drugs.com. Last updated on March 24, 2021.

Patiromer Levels and Effects while Breastfeeding

Summary of Use during Lactation

Because patiromer is not orally absorbed it is unlikely to reach the breastmilk or adversely affect the breastfed infant. No special precautions are required.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Sodium Polystyrene Sulfonate

Substance Identification

Substance Name

Patiromer

CAS Registry Number

1260643-52-4

Drug Class

  • Breast Feeding
  • Lactation
  • Cation Exchange Resins
  • Chelating Agents

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.